Postmanopausal osteoporosis management : a review of the evidence to inform the development of quality indicators /

This report aims to inform the development of quality indicators for postmenopausal osteoporosis management through: (a) assessing the evidence for screening and diagnosis of osteoporosis and related risk factors, and for prevention and treatment of osteoporosis and osteoporosis-related fractures; (...

Full description

Saved in:
Bibliographic Details
Corporate Authors: RAND Europe, Amgen Inc
Other Authors: Conklin, Annalijn
Format: Electronic eBook
Language:English
Published: Santa Monica, CA : RAND Europe, 2012.
Series:Technical report (Rand Corporation) ; TR-1247-AMGEN.
Subjects:
Online Access:Connect to this title online (unlimited users allowed)

MARC

LEADER 00000cam a2200000 a 4500
001 b3182670
003 CStclU
005 20240524050223.0
006 m o d
007 cr cn|||||||||
008 120614s2012 cau ob 000 0 eng
016 7 |a 101586328  |2 DNLM 
019 |a jdda847890378  |a jdda867483850  |a jdda903552990 
020 |a 9780833079848 
020 |a 0833079840 
027 |a RAND/TR-1247-AMGEN 
035 |a (OCoLC)jdda801916879 
035 |a (OCoLC)801916879  |z (OCoLC)847890378  |z (OCoLC)867483850  |z (OCoLC)903552990 
037 |a 22573/ctt36svrk  |b JSTOR 
040 |a NLM  |b eng  |e pn  |c NLM  |d KLG  |d OCLCF  |d RSM  |d JSTOR  |d YDXCP  |d TEF  |d OCLCQ  |d OCLCO  |d CUS  |d OCLCQ  |d LND  |d LOA  |d NLM  |d OCLCO  |d ICG  |d U3W  |d ERL  |d OCLCA  |d NJT  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
042 |a pcc 
043 |a e------ 
049 |a STAW 
050 4 |a RC931.O73  |b .P68 2012 
060 1 0 |a WE 250 
245 0 0 |a Postmanopausal osteoporosis management :  |b a review of the evidence to inform the development of quality indicators /  |c Annalijn Conklin [and others] ; prepared for Amgen. 
260 |a Santa Monica, CA :  |b RAND Europe,  |c 2012. 
300 |a 1 online resource (xv, 110 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Technical report ;  |v TR-1247-AMGEN 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- The diagnosis, prevention and treatment of postmenopausal osteoporosis -- Managing postmenopausal osteoporosis in Europe -- Informing the development of quality indicators for the management of postmenopausal osteoporosis -- Appendix A: Overview of guidelines in place in four countries -- Appendix B: Interview topic guide. 
520 3 |a This report aims to inform the development of quality indicators for postmenopausal osteoporosis management through: (a) assessing the evidence for screening and diagnosis of osteoporosis and related risk factors, and for prevention and treatment of osteoporosis and osteoporosis-related fractures; (b) describing current practice for managing postmenopausal osteoporosis in Europe; and (c) highlighting existing gaps in the evidence base and management practices in Europe. Analyses involved a comprehensive review of reviews regarding the screening and diagnosis of osteoporosis and related risk factors and the prevention and treatment of osteoporosis and osteoporosis-related fractures. While this identified a well developed evidence base on the effects of selected treatments on clinical outcomes of postmenopausal osteoporosis and associated fractures, and on the usefulness of selected simple risk factor assessment tools to identify postmenopausal women who would benefit from further diagnostic assessment, uncertainties remain regarding for example the optimal use of pharmacological interventions for preventive purposes and the effectiveness of population-based screening. We also carried out case study reviews of current practices for managing postmenopausal osteoporosis in England, France, Germany and Spain. We identify a need for the establishment of routine monitoring systems to enable better understanding of contemporary patterns and trends and identify care gaps in the management of postmenopausal osteoporosis and associated fractures. Such analyses are crucial to inform targeted strategies and policies to effectively address the burden of osteoporosis and associated fractures, which is sizable and set to increase across Europe. We set out considerations as a starting point for the further development of quality measures for postmenopausal osteoporosis in Europe. 
588 0 |a Online resource; title from PDF title page (viewed on July 9, 2012). 
650 0 |a Osteoporosis in women  |z Europe. 
650 0 |a Evidence-based medicine  |z Europe. 
650 0 |a Evidence-based medicine. 
650 0 |a Risk assessment. 
650 0 |a Outcome assessment (Medical care) 
651 0 |a Europe. 
650 1 2 |a Osteoporosis, Postmenopausal  |x therapy 
650 2 2 |a Evidence-Based Medicine 
650 2 2 |a Risk Assessment 
650 2 2 |a Treatment Outcome 
650 2 2 |a Quality Indicators, Health Care 
651 2 |a Europe 
651 6 |a Europe. 
650 7 |a risk assessment.  |2 aat 
650 7 |a Risk assessment  |2 fast 
650 7 |a Outcome assessment (Medical care)  |2 fast 
650 7 |a Evidence-based medicine  |2 fast 
650 7 |a Osteoporosis in women  |2 fast 
651 7 |a Europe  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJxCxPbbk4CPJDQJb4r6rq 
655 2 |a Review 
700 1 |a Conklin, Annalijn. 
710 2 |a RAND Europe. 
710 2 |a Amgen Inc. 
830 0 |a Technical report (Rand Corporation) ;  |v TR-1247-AMGEN. 
856 4 0 |u https://www.jstor.org/stable/10.7249/j.ctt3fh1vm  |z Connect to this title online (unlimited users allowed)  |t 0 
907 |a .b31826702  |b 240528  |c 181114 
998 |a uww  |b    |c m  |d z   |e l  |f eng  |g cau  |h 0 
919 |a .ulebk  |b 2024-02-15 
917 |a JSTOR Open Access Ebooks 
999 f f |i dc503cbe-be6c-5029-8a41-b1b7a11462d2  |s 6644dc38-67a4-56de-8fcc-d7a2bf88f153  |t 0